AstraZeneca plc
Global biopharmaceutical company focused on oncology, cardiovascular, respiratory and rare disease therapeutics.
Financial Snapshot
The AstraZeneca plc Story Through Numbers
AstraZeneca's Destiny 9 energy โ global and humanitarian in scope โ became globally visible during COVID-19, when the company pledged to supply its Oxford vaccine at cost to low-income countries, distributing over 3 billion doses worldwide. This wasn't simply good PR; it was a 9 company acting from its deepest nature. The oncology strategy โ acquiring Alexion for rare diseases and building one of the sector's most innovative cancer pipelines โ reflects 9's commitment to reaching the people most underserved by conventional medicine.
Investor alignment: Best aligned with Life Path 9 purpose-driven investors and Life Path 7 researchers who value scientific depth and global health impact.